- Home
- XELA vs KZIA Comparison
XELA vs KZIA Comparison
Compare XELA & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XELA
- KZIA
- Stock Information
- Founded
- XELA 2014
- KZIA 1994
- Country
- XELA United States
- KZIA Australia
- Employees
- XELA N/A
- KZIA N/A
- Industry
- XELA Business Services
- KZIA Biotechnology: Pharmaceutical Preparations
- Sector
- XELA Consumer Discretionary
- KZIA Health Care
- Exchange
- XELA Nasdaq
- KZIA Nasdaq
- Market Cap
- XELA 13.8M
- KZIA 12.6M
- IPO Year
- XELA N/A
- KZIA 1999
- Fundamental
- Price
- XELA $2.08
- KZIA $0.41
- Analyst Decision
- XELA
- KZIA Strong Buy
- Analyst Count
- XELA 0
- KZIA 1
- Target Price
- XELA N/A
- KZIA $2.00
- AVG Volume (30 Days)
- XELA 56.2K
- KZIA 553.5K
- Earning Date
- XELA 08-15-2024
- KZIA 10-22-2024
- Dividend Yield
- XELA N/A
- KZIA N/A
- EPS Growth
- XELA N/A
- KZIA N/A
- EPS
- XELA N/A
- KZIA N/A
- Revenue
- XELA $1,022,030,000.00
- KZIA $382.00
- Revenue This Year
- XELA $20.38
- KZIA $4,053,954.00
- Revenue Next Year
- XELA N/A
- KZIA N/A
- P/E Ratio
- XELA N/A
- KZIA N/A
- Revenue Growth
- XELA N/A
- KZIA N/A
- 52 Week Low
- XELA $1.83
- KZIA $0.19
- 52 Week High
- XELA $4.34
- KZIA $1.58
- Technical
- Relative Strength Index (RSI)
- XELA 44.69
- KZIA 53.72
- Support Level
- XELA $1.95
- KZIA $0.38
- Resistance Level
- XELA $2.11
- KZIA $0.46
- Average True Range (ATR)
- XELA 0.11
- KZIA 0.03
- MACD
- XELA -0.00
- KZIA 0.00
- Stochastic Oscillator
- XELA 16.67
- KZIA 48.45
About XELA Exela Technologies Inc.
Exela Technologies Inc is a business process automation (BPA) leader combining industry-specific and multi-industry enterprise software and solutions. The company's BPA suite of solutions is deployed in banking, healthcare, insurance, and other industries. The company's segment includes Information and Transaction Processing Solutions (ITPS), Healthcare Solutions (HS), and Legal and Loss Prevention Services (LLPS). It generates maximum revenue from the ITPS segment.
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors.